No profound question from me, but just a noteworthy day for ILMN and I was pleasantly surprised. It's up nearly 15% over the day, having beat earnings. I plan to hang on for the long term, but I was pleased it's back to 2015 levels.
Sounds like their new sequencer has been a big success, and they're talking about getting the cost of sequencing a whole genome down to $100. I don't think anybody would have foreseen that a decade ago, but that's the usual story! The real costs are going to be in analyzing the massive volumes of data.
Submitted August 02, 2017 at 08:28PM by Strix780 http://ift.tt/2u1PjRu
